Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode.
Completed · Phase 4 · Has a placebo group
Conditions studied: Acute Heart Failure
In brief
The purpose of this study was to assess the effect of in-hospital initiation of sacubitril/valsartan (LCZ696) vs. enalapril on time averaged proportional change in NT-proBNP in patients who have been stabilized following hospitalization for acute decompensated heart failure (ADHF) and reduced ejection fraction (left ventricular ejection fraction (LVEF) ≤ 40%).
Key facts
- Study ID
- NCT02554890
- Run by
- Novartis Pharmaceuticals
- People needed
- 887
- Starts
- 2016-04-29
- Expected to finish
- 2018-07-24
- Last updated by the study team
- 2021-01-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Fort Smith, Arkansas, United States
- Novartis Investigative Site — Little Rock, Arkansas, United States
- Novartis Investigative Site — Bakersfield, California, United States
- Novartis Investigative Site — Fresno, California, United States
- Novartis Investigative Site — Long Beach, California, United States
- Novartis Investigative Site — Los Angeles, California, United States
- Novartis Investigative Site — Los Angeles, California, United States
- Novartis Investigative Site — Orange, California, United States
- Novartis Investigative Site — Pasadena, California, United States
- Novartis Investigative Site — Sacramento, California, United States
- Novartis Investigative Site — San Diego, California, United States
- Novartis Investigative Site — San Marino, California, United States
- Novartis Investigative Site — San Pablo, California, United States
- Novartis Investigative Site — Stanford, California, United States
- Novartis Investigative Site — Denver, Colorado, United States
- Novartis Investigative Site — Littleton, Colorado, United States
- Novartis Investigative Site — Bridgeport, Connecticut, United States
- Novartis Investigative Site — Hartford, Connecticut, United States
- Novartis Investigative Site — Hartford, Connecticut, United States
- Novartis Investigative Site — West Haven, Connecticut, United States
- Novartis Investigative Site — Washington D.C., District of Columbia, United States
- Novartis Investigative Site — Atlantis, Florida, United States
- Novartis Investigative Site — Daytona Beach, Florida, United States
- Novartis Investigative Site — Fort Lauderdale, Florida, United States
- Novartis Investigative Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.